Roche Holding AG Equity-NMS: RHHBY

Healthcare

Drug Manufacturers - General

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$42.74

Open :

$42.91

Today's high :

$43.08

Today's low :

$42.8

52W low :

$33.0054

52W high :

$43.08

EPS(TTM): :

1.83

Shares O/S :

5.52 B

Market cap :

237.4 B

What is the share price of Roche Holding AG today?

Roche Holding AG (RHHBY) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Roche Holding AG?

Yes, Indian Investors can invest in the Roche Holding AG (RHHBY) Share by opening an international trading account with Angel One.

How can I purchase Roche Holding AG shares in India?

Purchasing Roche Holding AG (RHHBY) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Roche Holding AG (RHHBY) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Roche Holding AG?

Yes, you can purchase fractional shares of Roche Holding AG (RHHBY) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Roche Holding AG?

The market capitalization of Roche Holding AG on January 1, 1970, is $0.

What documents are required to invest in Roche Holding AG stocks?

In order to invest in Roche Holding AG (RHHBY) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.